Metto (metronidazole) is an effective antiprotozoal and antimicrobial agent of a broad spectrum of action.

Levofloxacin is a fluoroquinolone, a broad-spectrum bactericidal agent. The mechanism of action is to inhibit bacterial topoisomerase IV and DNA gyrase (topoisomerase II) - enzymes necessary for replication, transcription, recovery and recombination of bacterial DNA.

Infusion solution of L-amino acids for parenteral nutrition. Amino acids are components necessary for protein synthesis. The amino acids contained in the preparation are in the L-form, which provides the possibility of their direct participation in protein biosynthesis. Solutions containing amino acids are used for parenteral nutrition simultaneously with energy carriers, electrolytes and fluid to support or improve the condition of the body or minimize weight loss.

Antianemic agent. It is a colloidal solution that consists of spheroidal iron-carbohydrate nanoparticles. In the nucleus (center) of each particle there is iron (III) hydroxide. The core is surrounded by a sucrose shell, which stabilizes iron (III) hydroxide, slowly releases biactive iron and preserves the resulting particles in a colloidal solution. As a result, a complex is formed, the molecular weight of which is approximately 43 kD, as a result of which its excretion through the kidneys in unchanged form is impossible. Iron (III) in this complex is associated with structures similar to natural ferritin.

Fluzanex is a general antifungal drug of bis-triazole type. The mechanism of the antifungal action of the drug consists in the specific inhibition of the biosynthesis of ergosterol, which is necessary for the construction of the cell membrane of fungi.

Citicoline stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which contributes to improving the function of membranes, including the functioning of ion exchange pumps and neuroreceptors. Due to its stabilizing effect on the membrane, citicoline has an anti-edematous effect, reduces cerebral edema. Citicoline weakens the severity of symptoms associated with cerebral dysfunction after such pathological processes as traumatic brain injury and acute disorders of cerebral circulation. Reduces the level of amnesia, improves the condition of cognitive, sensory and motor disorders. Citicoline improves the symptoms that are observed in hypoxia and cerebral ischemia, including memory impairment, emotional lability, difficulties in daily work and self-service.

Citicoline stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which contributes to the improvement of membrane functions, including the functioning of ion exchange pumps and neuroreceptors. Due to its stabilizing effect on the membrane, citicoline has anti-edematous properties, so it reduces brain edema. Citicoline inhibits the activity of some phospholipases, prevents the residual release of free radicals, prevents damage to membrane systems and ensures the preservation of the protective antioxidant system.